Navigation Links
Accuray Incorporated's CEO to Speak at Jefferies Second Annual Healthcare Conference
Date:6/18/2008

n improved quality of life and a non-surgical treatment option for those diagnosed with cancer. Accuray develops and markets the CyberKnife Robotic Radiosurgery System, which extends the benefits of radiosurgery to include extracranial tumors, including those in the spine, lung, prostate, liver and pancreas. To date, the CyberKnife System has been used to treat more than 40,000 patients worldwide and currently more than 130 systems have been installed in leading hospitals in the Americas, Europe and Asia. For more information, please visit http://www.accuray.com.


'/>"/>
SOURCE Accuray Incorporated
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Accuray Receives FDA Clearance for New Dose Calculation Technique for Body Radiosurgery
2. Accuray Incorporateds CEO to Speak at UBS Global Life Sciences Conference
3. Accuray to Webcast Senior Management Presentations at Analyst Day Event
4. Accuray Incorporated to Report First Quarter Fiscal Year 2008 Financial Results
5. Accuray Incorporated to Host Investor and Analyst Meeting at ASTRO 2007
6. Accuray Announces Four New Products at Nations Leading Radiation Oncology Meeting
7. Accuray Reports Record Revenue in First Quarter of Fiscal 2008
8. Accuray Exceeds 4,000 Lung Cancer Patients Treated with CyberKnife(R) System
9. Accuray Incorporated to Report Second Quarter Fiscal Year 2008 Financial Results
10. Accuray Reports Continued Growth in Second Quarter of Fiscal 2008
11. Accurays CyberKnife System Receives 2008 North American Medical Devices Product of the Year Award From Frost & Sullivan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2008)... Americans were infected last year , , T...er U.S. health officials recommended routine HIV t...s hit-and-miss, and the AIDS epidemic marches on. ...better testing methods, according to participants ...eting was designed to review the state of the AIDS...
(Date:11/20/2008)...ction Plan and Begins Marketing; John Strong, Form... Group, Consorta, Inc., to Lead Sales and Marketin.../ -- The world,s first permanent international hea... in less than five years, the key players driving ...anhattan tower have been finalized and marketing h...
(Date:11/20/2008)... Emerson Ecologics, LLC today,announced the acqui..., also,known as TIDhealth, of Redlands, CA, a lea...ents to the professional integrative healthcare ma...ealth creates the leading U.S. provider,of integr...-growth,professional nutritional supplements mark...
(Date:11/20/2008)...-- Want to lower your risk for type,2 diabetes an... a big,difference. A study called the Diabetes Pr... to 10 percent of your weight can prevent or delay...erson, 5 percent is just 9,pounds. , In th...betes, and heart,disease is the leading cause of ...
Breaking Medicine News(10 mins):Health News:U.S. Lags on HIV Testing Goals 2Health News:U.S. Lags on HIV Testing Goals 3Health News:Permanent International Healthcare Marketplace and Education Center Set to Open in New York City in 2013 2Health News:Permanent International Healthcare Marketplace and Education Center Set to Open in New York City in 2013 3Health News:Permanent International Healthcare Marketplace and Education Center Set to Open in New York City in 2013 4Health News:Permanent International Healthcare Marketplace and Education Center Set to Open in New York City in 2013 5Health News:Emerson Ecologics Announces Acquisition of TIDhealth 2Health News:Emerson Ecologics Announces Acquisition of TIDhealth 3Health News:The 5-Percent Plan: Preventing Diabetes and Heart Disease 2
...’s disease leads to a drastic fall in the capabili...fore much of our research and strategies // have f...onclusion that patients suffering Alzheimer’s do n...y researchers at Melbourne's Howard Florey Institu...
...study in genetically engineered mice has revealed ...to damage kidneys used for transplants may also he...at Johns Hopkins. Researchers have long known that...eturned to transplanted kidneys or other organs, i...
...t University Medical Center has become the first h... cardiac surgery//, which doctors believe will cha...ts. Called the Hybrid OR/Cath Lab, the state-of-t...equipment and monitoring devices necessary to perf...
...men are more likely to have twins, says a new stud...earch into multiple-birth pregnancies //at the Lon...heights of 129 women. According to his study, 10...o twins and 24 to triplets, reported newswise wire...
Other Medicine News:Health News:Study Reveals Effects of WBCs on Transplanted Kidney 2Health News:Study Reveals Effects of WBCs on Transplanted Kidney 3Health News:A New Approach to Heart Bypass Surgery Provides Patients with 'One-stop Shopping' 2Health News:A New Approach to Heart Bypass Surgery Provides Patients with 'One-stop Shopping' 3Health News:A New Approach to Heart Bypass Surgery Provides Patients with 'One-stop Shopping' 4
(Date:11/20/2008)...W YORK, Nov. 20 Clinical data from...e 35th Annual Veith Symposium shows DVT,treatment...om Bacchus,Vascular, Inc. (Santa Clara, CA) succe... in about 20 minutes. , This technique, cal...ores,blood flow more quickly and safely than curr...
(Date:11/19/2008)...OUSAND OAKS, Calif., Nov. 19 /PRNewswire-FirstCall...Takeda Oncology Company, a subsidiary of,Takeda P...nnounced that,enrollment in the Phase 3 MONET1 tr... with paclitaxel and carboplatin for the first-lin...r (NSCLC) has been temporarily suspended,followin...
(Date:11/19/2008)...WARK, Del., Nov. 19 Isogen, a cont...or sterile filling, today announced the first,pha...ogen was founded to,specifically address the proc...ciated with the $2 billion highly-niched, low-volu...lling market segment. , Companies can inves...
(Date:11/18/2008)...LVERN, Pa., Nov. 18 Arlington Medi... intelligence for the pharmaceutical and diagnosti... of CSL Behring,s Privigen was,sold in the U.S. d...ewest,brand of intravenous immune globulin (IVIG)...VIG is a product created from the blood plasma of ...
Breaking Medicine Technology:Trellis(R) Peripheral Infusion System Removes Blood Clots in Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series 2Trellis(R) Peripheral Infusion System Removes Blood Clots in Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series 3Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 2Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 3Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 4Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 5Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 6Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 7Isogen Launches Major New Facility to Address Global Biopharma Demand 2Over $10 Million of CSL Behring's Privigen Was Sold in the U.S. During the Third Quarter of 2008 2Cha Ching 21 Seniors Enrolled in Medicare Prescription Drug Plans Might Be in for Sticker Shock Next Year 6000 1Cha Ching 21 Seniors Enrolled in Medicare Prescription Drug Plans Might Be in for Sticker Shock Next Year 6000 2Cha Ching 21 Seniors Enrolled in Medicare Prescription Drug Plans Might Be in for Sticker Shock Next Year 6000 3Cha Ching 21 Seniors Enrolled in Medicare Prescription Drug Plans Might Be in for Sticker Shock Next Year 6000 4Non Profit Calls on Mental Health Professionals to Honor Veterans Day by Giving an Hour of Free Counseling to Returning Veterans 5998 1Non Profit Calls on Mental Health Professionals to Honor Veterans Day by Giving an Hour of Free Counseling to Returning Veterans 5998 2Southern Research Expands Sales and Marketing Agreement with Absorption Systems to Service European Market 1763 1Southern Research Expands Sales and Marketing Agreement with Absorption Systems to Service European Market 1763 2New Data Presented on the Renessa 28R 29 Treatment for Female Stress Urinary Incontinence 822 1New Data Presented on the Renessa 28R 29 Treatment for Female Stress Urinary Incontinence 822 2New Data Presented on the Renessa 28R 29 Treatment for Female Stress Urinary Incontinence 822 3
... June 21, 2007 /PRNewswire-FirstCall/ - Biotech,Ho...n has given,Biotech,s "Sucanon" diabetes drug its ... in the May-June 2007 issue of Diabetes,Hoy, the D...ne for,doctors and other health professionals. , T...rto Cepeda,Gonzalez, Medical Director of the Speci...
...y to Indicate that Early Use of Estrogen May be,Ca...e-USNewswire/ -- A new analysis,of Women,s Health ...al of Medicine, shows significant reduction in cal...e therapy (HT) compared,with women taking a placeb... estrogen therapy and coronary artery calcium,(CAC...
Other Medicine Technology:Diabetes drug supported by Mexican Diabetes Federation 2Diabetes drug supported by Mexican Diabetes Federation 3Arterial Plaque Significantly Reduced in Women Age 50-59 Taking,Hormones, Says New Analysis of Women's Health Initiative Data 2Arterial Plaque Significantly Reduced in Women Age 50-59 Taking,Hormones, Says New Analysis of Women's Health Initiative Data 3
...an be used to screen out patients negative for ant...ious systemic rheumatic diseases such as Systemic ...xed connective tissue disease, progressive systemi...sitis, and Raynaud's phenomenon. They can also be ...
...an be used to screen out patients negative for ant...ious systemic rheumatic diseases such as Systemic ...xed connective tissue disease, progressive systemi...sitis, and Raynaud's phenomenon. They can also be ...
...an be used to screen out patients negative for ant...ious systemic rheumatic diseases such as Systemic ...xed connective tissue disease, progressive systemi...sitis, and Raynaud's phenomenon. They can also be ...
The PANBIO Inc. Indirect Fluorescence Assay (IFA) for Anti-native DNA (nDNA) IgG Antibody is intended for the qualitative and semi-quantitative detection of IgG (Immunoglobulin G) antibody to nDNA in
Medicine Products: